tenk.fyi

Kyverna Therapeutics, Inc.

KYTXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$161.3M

26.5% YoY

EPS

$-3.64

9.3% YoY

Cash

$124.1M

28.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro